A PHASE-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH AUTOLOGOUS MARROW SUPPORT IN WOMEN WITH MEASURABLE ADVANCED BREAST-CANCER RESPONDING TO STANDARD-DOSE THERAPY

被引：380

作者：

ANTMAN, K

AYASH, L

ELIAS, A

WHEELER, C

HUNT, M

EDER, JP

TEICHER, BA

CRITCHLOW, J

BIBBO, J

SCHNIPPER, LE

FREI, E

机构：

[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT STAT, BOSTON, MA 02115 USA

[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT CANC PHARMACOL, BOSTON, MA 02115 USA

[3] BETH ISRAEL HOSP, DEPT MED & SURG, BOSTON, MA 02215 USA

[4] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 01期

关键词：

D O I：

10.1200/JCO.1992.10.1.102

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：102 / 110

页数：9

共 72 条

[1]

ANTMAN K, 1991, UCLA SYM BI, V137, P423

[2]

ANTMAN K, 1987, CANCER TREAT REP, V71, P119

[3]

BERETTA G, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P77

[4]

BEVERIDGE RA, 1988, P ASCO, V7, P13

[5]

BITRAN JD, 1987, BREAST CANCER RES TR, V10, P88

[6]

BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[7] THE DOSE DILEMMA [J].

CANELLOS, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) :1363-1364

[8] SURVIVAL FROM 1ST RECURRENCE - RELATIVE IMPORTANCE OF PROGNOSTIC FACTORS IN 1,015 BREAST-CANCER PATIENTS [J].

CLARK, GM ;

SLEDGE, GW ;

OSBORNE, CK ;

MCGUIRE, WL .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :55-61

[9]

DUNPHY F, 1989, P AN M AM SOC CLIN, V8, P25

[10]

DUNPHY FR, 1989, TANDEM HIGH DOSE CHE, P245

← 1 2 3 4 5 6 7 8 →